Heparin-binding epidermal growth factor-like growth factor: A hepatic stellate cell proliferation inducer via ErbB receptors

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 3, 2014, Pages 623-632

  Zhang, Di ^a   Zhang, Jian ^a   Jiang, Xiaoyu ^b   Li, Xiaojun ^a   Wang, Yan ^a   Ma, Junji ^a   Jiang, Huiqing ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Epidermal growth factor receptor; Heparin binding epidermal growth factor like growth factor; Hepatic stellate cells; Proliferation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ALPHA SMOOTH MUSCLE ACTIN; CASPASE 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MESSENGER RNA; PROTEIN KINASE B;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; MAP KINASE ASSAY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STELLATE CELL; WESTERN BLOTTING;

APOPTOSIS; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN-BINDING EPIDERMAL GROWTH FACTOR-LIKE GROWTH FACTOR; HEPATIC STELLATE CELLS; PROLIFERATION;

ANIMALS; APOPTOSIS; CELL LINE; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; HEPATIC STELLATE CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER CIRRHOSIS; MALE; MOLECULAR TARGETED THERAPY; ONCOGENE PROTEIN V-AKT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84897631682     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12412     Document Type: Article

References (42)

1. Osterrecher CH, Stickel F, Brenner DA. Genomics of liver fibrosis and cirrhosis. Semin. Liver Dis. 2007; 27: 28-43.
2. Lotersztajn S, Julien B, Teixeira-Clerc F, Grenard P, Mallat A. Hepatic fibrosis: molecular mechanisms and drug targets. Annu. Rev. Pharmacol. Toxicol. 2005; 45: 605-628.
3. Eng FJ, Friedman SL, Fibrogenesis I. New insights into hepatic stellate cell activation: the simple becomes complex. Am. J. Phsiol. Gastrointest. Liver Physiol. 2000; 279: G7-G11.
4. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134: 1655-1669.
5. Anan A, Baskin-Bey ES, Bronk SF, Werneburg NW, Shah VH, Gores GJ. Proteasome inhibition induces hepatic stellate cell apoptosis. Hepatology 2006; 43: 335-344.
6. Kinnman N, Goria O, Wendum D etal. Hepatic stellate cell proliferation is an early platelet-derived growth factor-mediated cellular event in rat cholestatic liver injury. Lab. Invest. 2001; 81: 1709-1716.
7. Kuriyama S, Yokoyama F, Inoue H etal. Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model. Int. J. Mol. Med. 2007; 19: 317-324.
8. Hellerbrand C, Stefanovic B, Giordano F, Burchardt ER, Brenner DA. The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo. J. Hepatol. 1999; 30: 77-87.
9. Goishi K, Higashiyama S, Klagsbrun M etal. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol. Biol. Cell 1995; 6: 967-980.
10. Fu Y, Chen A. The phyto-chemical (-)-epigallocatechin gallate suppresses gene expression of epidermal growth factor receptor in rat hepatic stellate cells in vitro by reducing the activity of Egr-1. Biochem. Pharmacol. 2006; 72: 227-238.
11. Deb TB, Su L, Wong L etal. Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF. J. Biol. Chem. 2001; 276: 15554-15560.
12. Ono M, Hirata A, Kometani T etal. Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation. Mol. Cancer Ther. 2004; 3: 465-472.
13. Navolanic PM, Steelman LS, McCubrey JA. EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review). Int. J. Oncol. 2003; 22: 237-252.
14. Iwamoto R, Handa K, Mekada E. Contact-dependent growth inhibition and apoptosis of epidermal growth factor (EGF) receptor-expressing cells by the membrane-anchored from of heparin-binding EGF-like growth factor. J. Biol. Chem. 1999; 274: 25906-25912.
15. Miyamoto S, Yagi H, Yotsumoto F, Kawarabayashi T, Mekada E. Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy. Cancer Sci. 2006; 97: 341-347.
16. Yamazaki S, Iwamoto R, Saeki K etal. Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities. J. Cell Biol. 2003; 163: 469-475.
17. Block ER, Matela AR, SundarRaj N, Iszkula ER, Klarlund JK. Wounding induces motility in sheets of corneal epithelial cells through loss of spatial constraints: role of heparin-binding epidermal growth factor-like growth factor signaling. J. Biol. Chem. 2004; 279: 24307-24312.
18. Mine N, Iwamoto R, Mekada E. HB-EGF promotes epithelial cell migration in eyelid development. Development 2005; 132: 4317-4326.
19. Shishido Y, Sharma KD, Higashiyama S, Klagsbrun M, Mekada E. Heparin-like molecules on the cell surface potentiate binding of diphtheria toxin to the diphtheria toxin receptor/membrane-anchored heparin-binding epidermal growth factor-like growth factor. J. Biol. Chem. 1995; 270: 29578-29585.
20. Reynolds CM, Eguchi S, Frank GD, Motley ED. Signaling mechanisms of heparin-binding epidermal growth factor-like growth factor in vascular smooth muscle cells. Hypertension 2002; 39: 525-529.
21. Zhang XL, Liu JM, Yang CC etal. Dynamic expression of extracellular signal-regulated kinase in rat liver tissue during hepatic fibrogenesis. World J. Gastroenterol. 2006; 12: 6379-6381.
22. Ma J, Li F, Liu L etal. Raf kinase inhibitor protein inhibits cell proliferation but promotes cell migration in rat hepatic stellate cells. Liver Int. 2009; 29: 567-574.
23. Xu L, Hui AY, Albanis E etal. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 2005; 54: 142-151.
24. Vogel S, Piantedosi R, Frank J etal. An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J. Lipid Res. 2000; 41: 882-893.
25. Thomas R, Kim MH. HIF-1 alpha: a key survival factor for serum-deprived prostate cancer cells. Protate 2008; 68: 1405-1415.
26. Tankiewicz-Kwedlo A, Pawlak D, Domaniewski T, Buczko W. Effect of erythropoietin, 5-fluorouracil and SN-38 on the growth of DLD-1 cells. Pharmacol. Rep. 2010; 62: 926-937.
27. Li J, Garnette CS, Cahn M etal. Recombinant thrombomodulin inhibits arterial smooth muscle cell proliferation induced by thrombin. J. Vasc. Surg. 2000; 32: 804-813.
28. Zhang A, Xue H, Ling X etal. Anti-HER-2 engineering antibody ChA21 inhibits growth and induces apoptosis of SK-OV-3 cells [Abstract]. J. Exp. Clin. Cancer Res. 2010; 29: 23A.
29. Xia PY, Zheng J, Zhou H, Pan WD, Qin XJ, Xiao GX. Relationship between lymphocyte apoptosis and endotoxin translocation after thermal injury in rats. World J. Gastroenterol. 2002; 8: 546-550.
30. Wang Y, Jiang XY, Liu L, Jiang HQ. Phosphatidylinositol 3-kinase/Akt pathway regulates hepatic stellate cell apoptosis. World J. Gastroenterol. 2008; 14: 5186-51891.
31. Bachawal SV, Wali VB, Sylvester PW. Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells [Abstract]. BMC Cancer 2010; 10: 84A.
32. Martarelli D, Pompei P, Mazzoni G. Inhibition of adrenocortical carcinoma by diphtheria toxin mutant CRM197. Chemotherapy 2009; 55: 425-432.
33. Blaine SA, Ray KC, Branch KM, Robinson PS, Whitehead RH, Means AL. Epidermal growth factor receptor regulates pancreatic fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2009; 297: G434-G441.
34. Kiso S, Kawata S, Tamura S etal. Expression of heparin-binding epidermal growth factor-like growth factor in the hepatocytes of fibrotic rat liver during hepatocarcinogenesis. J. Gastroenterol. Hepatol. 1999; 14: 1203-1209.
35. Huang G, Besner GE, Brigstock DR. Heparin-binding epidermal growth factor-like growth factor suppresses experimental liver fibrosis in mice. Lab. Invest. 2012; 92: 703-712.
36. Takemura T, Yoshida Y, Kiso S etal. Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice. Biochem. Biophys. Res. Commun. 2013; 437: 185-191.
37. Wang YD, De Vos J, Jourdan M etal. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells. Oncogene 2002; 21: 2584-2592.
38. Zhang J, Li H, Wang J, Dong Z, Mian S, Yu FS. Role of EGFR transactivation in preventing apoptosis in Pseudomonas aeruginosa-infected human corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 2004; 45: 2569-2576.
39. Jackson LF, Qiu TH, Sunnarborg SW etal. Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J. 2003; 22: 2704-2716.
40. Sartor CL, Zhou H, Kozlowska E etal. Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells. Mol. Cell. Biol. 2001; 21: 4265-4275.
41. Jessmon P, Kilbum BA, Romero R, Leach RE, Armant DR. Function-specific intracellular signaling pathways downstream of heparin-binding EGF-like growth factor utilized by human trophoblasts. Biol. Reprod. 2010; 82: 921-929.
42. Wang Y, Gao J, Zhang D, Zhang J, Ma J, Jiang H. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. J. Hepatol. 2010; 53: 132-144.